Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-02-13
2007-02-13
Nickol, Gary B. (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000, C530S351000, C435S069700
Reexamination Certificate
active
10047264
ABSTRACT:
The present invention provides novel isolated CRF2-12 polynucleotides and polypeptides encoded by the CRF2-12 polynucleotides. Also provided are the antibodies that immunospecifically bind to a CRF2-12 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the CRF2-12 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the CRF2-12 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
REFERENCES:
patent: 5319071 (1994-06-01), Dower et al.
patent: 6740520 (2004-05-01), Goddard et al.
patent: 6875845 (2005-04-01), Presnell et al.
patent: 6897292 (2005-05-01), Presnell et al.
patent: 2003/0022827 (2003-01-01), Weiss et al.
patent: 2003/0219862 (2003-11-01), Agarwal et al.
patent: 1 191 035 (2002-03-01), None
patent: WO 01/36467 (2001-05-01), None
patent: WO 01/40467 (2001-06-01), None
patent: WO 01/46422 (2001-06-01), None
patent: WO 01/66740 (2001-09-01), None
patent: WO 01/98342 (2001-12-01), None
patent: WO 02/12345 (2002-02-01), None
patent: WO 02/24888 (2002-03-01), None
patent: WO 02/24912 (2002-03-01), None
patent: WO 02/070655 (2002-09-01), None
Dumoutier, et al. (2001). J Immun 166(12): 7090-7095.
Gruenberg, et al. (2001). Gen Immun 2(6): 329-334.
Kotenko and Pestka (2000). Oncogene 19: 2557-2565.
Kotenko, et al. (2001). J Immun 166(12): 7096-7103.
Xu, et al. (2001). Proc Natl Acad Sci USA 98(17): 9511-9516.
Deng Bijia
Fouser Lynette
Liu Wei
Finnegan Henderson Farabow Garrett & Dunner LLP
Jiang Dong
Nickol Gary B.
Wyeth
LandOfFree
Type 2 cytokine receptor and nucleic acids encoding same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Type 2 cytokine receptor and nucleic acids encoding same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Type 2 cytokine receptor and nucleic acids encoding same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3890824